Cramer says Chipotle is a huge winner while his 'four horsemen' of Celgine, Gilead Sciences, Regeneron and Biogen Idec are pulling away from the biotech pack.
Cramer prefers EOG Resources over Magnum Hunter and Dow Chemical over PolyOne.
Should investors settle for average results? Absolutely not, Cramer says.
Cramer still believes in Apple, sees Chipotle succeeding over McDonald's and is a fan of Interpublic.
Cramer is bullish on Huntington Bancshares but likes Cedar Fair better than Six Flags.
During earnings week stocks are up against terrible odds and the market's reactions to news can be totally out of sync with reality, Cramer warns.
Cramer says Chipotle's earnings are hot, Honeywell remains a buy and St. Jude Medical has a healthy pipeline of new products.
Cramer is bullish on Sunoco Logistics Partners and Sanchex Energy but he would not own Tumi Holdings.
There's no reason to start selling but there's also no reason to run out and buy either, Cramer says.
Earnings alone won't be enough to guide you through next week's trading in this time of global uncertainty, Cramer says.